Cardiometabolic Risk in First Episode Psychosis Patients

Previous research in patients with schizophrenia in European and USA population groups has demonstrated a high prevalence of metabolic syndrome and disease progression (~35%–40%) and increased risk for cardiovascular disease and long-term mortality. Limited research has determined the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jo, Griffiths, Lisa A., Band, Marie, Horne, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732528/
https://www.ncbi.nlm.nih.gov/pubmed/33329382
http://dx.doi.org/10.3389/fendo.2020.564240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732528/
https://www.ncbi.nlm.nih.gov/pubmed/33329382
http://dx.doi.org/10.3389/fendo.2020.564240

Ejemplares similares